Mills & Reeve advises on construction of advanced cancer research hospital
The Cambridge Cancer Research Hospital (CCRH) will be a 26,000m2 state of the art facility built in the heart of Cambridge.
All-inclusive service provided by the Epicentre, Haverhill allows universal genomics company MultiplAI to grow and move on
Its onwards and upwards for MultiplAI, a fast-expanding techbio company developing RNA-based, AI-driven, universal genomic screening for cardiovascular and other complex diseases, that has benefited from the flexible terms and business support offered by The EpiCentre in Haverhill.'
Arecor announces positive pre-IND meeting with FDA for novel ready-to-use medicine AT307 licensed to Hikma
Cambridge, UK - Arecor, the biopharmaceutical group advancing today’s therapies to enable healthier lives, announces further progress from Hikma in the development of ready-to-use ("RTU") injectable medicine AT307, following a recent positive pre-investigational new drug application (pre-IND) meeting between Hikma and the US Food and Drug Administration (FDA).
Essential building blocks for business success from founder of Axiom-e
Last term, Ken Dickson, the founder of Axiom-e, ran three versions of 'The Pillars of Business Success' course to audiences drawn from more than 20 countries. His first talk of this term will be at the Quadram Institute, a state-of-the-art facility for bioscience and clinical research, and endoscopy, based at the Norwich Research Park
What connects the world’s first wheelchair toddler with a world-famous Cambridge scientist?
What connects the world’s first wheelchair toddler with a world-famous Cambridge scientist?
Is it time for a health insurance black box?
electronRx writes...Telematics Insurance was marketed as a revolution in car insurance for the under-25s when Aviva first introduced the motor insurance policy in 2005. By agreeing to a GPS-tracked' Black Box' in their vehicle, young drivers could enjoy dramatically reduced premiums by proving they were safe and responsible on the road.
CN Bio and LifeNet Health LifeSciences partner to supply validated primary human cells for microphysiological systems
Cambridge, UK - CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems (MPS), and LifeNet Health LifeSciences, “LifeNet Health”, a non-profit, global leader in all-human research solutions, announces a strategic partnership to supply validated primary human cells for use with CN Bio’s PhysioMimix® OOC range of MPS.
Positive body image linked to better life satisfaction
Largest study of its kind also finds people in rural areas appreciate their bodies more
Revvity unveils next-generation preclinical imaging technologies to help scientists drive breakthrough discoveries
WALTHAM, Mass., Revvity, Inc. debuts its enhanced imaging portfolio designed to drive innovation across diverse applications in preclinical research with the launch of three systems.
Yourgene Health launches MagBench Automated DNA Extraction Instrument and Kit for NIPT Workflows
Offers clinical labs in APAC and Middle East cost-efficient, bench-top robotic cell-free DNA extraction workstation and reagents for Yourgene’s Sage 32 NIPT Workflow.
Wearable therapeutics that are changing the face of healthcare
Wearable technology has many advantages in healthcare. In diagnostics, wearables can provide always-on data collection, enabling faster and more accurate clinical decisi
Moving on up: Guardtech Group celebrate continued growth with switch to stunning new home
Cleanroom construction experts putting finishing touches on impressive new Guardtech House HQ in Haverhill.
TherageniX and University of Nottingham Awarded £995K Innovate UK grant to develop powdered gene therapy for bone regeneration
London, UK, and Nottingham, UK - TherageniX, a University of Nottingham spin out pioneering a dry powder gene therapy formulation for bone graft augmentation, and its collaborator, the University of Nottingham, have been awarded a £995,000 grant from Innovate UK, the UK’s innovation agency. The funding will support the development of the Company’s gene therapy in a powder, a non-viral gene…
Five ways to combat new job nerves when you hire
Studies show that 80% of people are nervous before starting a new job. Having spent time and money on the recruitment process, you'll want to make sure your new employees have a smooth onboarding process and hit the ground running as soon as possible.
Optibrium acquires BioPharmics LLC, expanding its 3D drug design and visualisation offering
BioPharmics’ Drs Ajay Jain (CEO) and Ann Cleves (Director of Applied Science) join the Optibrium team as Vice Presidents in the newly-created BioPharmics Division.
Intellegens and CPI awarded £1.6m Innovate UK grant to advance manufacture of oligonucleotide therapeutics with machine learning
Cambridge, UK - Intellegens, a company applying machine learning (ML) to accelerate innovation in R&D, announces that it has secured a £1.6m grant from Innovate UK, part of UK Research and Innovation (UKRI), to apply ML in the emerging field of oligonucleotide therapies.
CN Bio appoints Dr. Tomasz Kostrzewski as Chief Scientific Officer
Cambridge, UK, 30th August 2023: CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems (MPS), today announced the appointment of Dr. Tomasz Kostrzewski as Chief Scientific Officer.
Key human bladder cancer genes pinpointed in cats and dogs
Key bladder cancer genes have been uncovered through studying the cancers in cats and dogs, in a significant stride for finding which of many mutations are the most important in the cancer’s development.
Bio-Rad Launches First StarBright™ Red Dye and Extends Range of Antibody Markers Conjugated to StarBright Dyes to Enhance Multiplex Flow Cytometry and Research Capabilities
With 29 additional targets the range also includes dog, cow, and pig targets to support translational models in veterinary immunology research.
GADx’s rapid diagnostic test, BotrytisAlert, demonstrates utility across wine production system
Lateral flow test enables Botrytis concentration to be measured in grape must and in finished wine, in addition to monitoring in the vineyard Ten-minute test is simple to use by agronomists and wine growers to address 25% losses in turnover due to BotrUbiquigent appoints Dr Rishi Shah as Head of Chemistry
Appointment brings extensive heterobifunctional and chemical biology expertise in house to drive forward Ubiquigent’s internal DUBTAC drug discovery and DUB-focused partnerships
Unique new technology enhances mobile functionality in healthcare
Cambridge based health tech company, electronRx, has developed an API solution for mobile phones that will be a step change in healthcare.
Celebrating our Centres - Exeter
This week we hear from our colleagues in the southwest about post-pandemic recruitment milestones, engaging with local community at agricultural shows, their Cystic Fibrosis and Monogenic Beta Cell Diabetes team, and collaborative work to increase the diversity of public involvement groups.
An international comparative analysis and roadmap to sustainable biosimilar markets
This study was originally published in Frontiers in Pharmacology.
Cleopatra Pal joins Salus Wellness Clinics
Salus Wellness Clinics writes...we are very pleased to announce that Cleopatra Pal has joined Salus Wellness this month.